Clinical trial Recruiting at 1 site Interventional Ages 7 to 25

Mind-body therapies to help anxiety in young cancer survivors

Official title: IMpact of Mind-body Therapies (HYpnosis and Relaxation) on Anxiety in Children, Adolescents and Young Adults Who Had Been Treated in ONcology. Multicenter Study.

Run by Centre Hospitalier Universitaire de Saint Etienne · NCT07380672 · Data updated 2026-11-12

This study tests whether hypnosis and relaxation, added to usual care, can reduce anxiety in children, teens, and young adults who have survived cancer.

Quick facts

Study typeInterventional
Ages7 Years to 25 Years
SexAll
Enrollment558 (estimated)
SponsorCentre Hospitalier Universitaire de Saint Etienne
Academic / other
Locations5 sites (Caen and 4 other locations)
StatusRecruiting
StartedAugust 4, 2026
Main results expectedJanuary 1, 2028
Study endsJuly 1, 2028
Registry record updatedAugust 7, 2026
Trial IDNCT07380672 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pediatric, adolescent, or young adult cancer survivors in remission, aged 7–25, with significant anxiety and access to follow-up care at participating centers.

Probably not a fit

Individuals without persistent anxiety or those not adherent to a follow-up schedule may see little or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter study explores whether incorporating mind-body therapies like hypnosis or relaxation alongside standard psychological care can help reduce anxiety symptoms in pediatric and young adult cancer survivors. Participants are split into age-based cohorts and choose either hypnosis or relaxation, with ten MBT sessions and nine standard care sessions over a defined period. The trial enrolled individuals who are in remission, completed intensive treatment at least three months prior, and meet anxiety criteria. Outcomes focus on changes in anxiety, with secondary observations on mood and overall well-being. It is conducted at three French centers with parental and participant consent required.

Why it matters

Potential benefit: If successful, participants may experience reduced anxiety and improved quality of life after cancer treatment.

How similar studies have gone: Previous studies suggest mind-body therapies can help anxiety in various populations, but evidence in pediatric cancer survivors is limited and this approach is relatively novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

HARMONY KIDS

* Patients aged at least 7 and under 15 at the time of inclusion, diagnosed with pediatric cancer,
* Patients considered to be in complete remission from pediatric cancer, whose intensive treatment ended at least 3 months prior to inclusion
* Patients receiving follow-up care after pediatric cancer at one of the participating centers,
* Patients with anxiety disorders (SCARED-R score ≥ 31)
* Patients affiliated with or eligible for social security,
* Patients and their parents (or legal guardians) who have received informed consent about the study and co-signed, with the investigator, a consent form to participate in the study.

HARMONY AYA

* Patients aged at least 15 and no more than 25 years old at the time of inclusion, diagnosed with pediatric cancer before the age of 18,
* Patients considered to be in complete remission from pediatric cancer, whose intensive treatment ended at least 3 months prior to inclusion,
* Patients receiving follow-up care after pediatric cancer at one of the participating centers,
* Patients with anxiety disorders (HADS-Anxiety score ≥ 8)
* Patients affiliated with or eligible for social security,
* For adult patients: patients who have received informed information about the study and have co-signed, with the investigator, a consent form to participate in the study,
* For minors: patients and their parents (or legal guardians) who have received informed consent about the study and have co-signed, with the investigator, a consent form for participation in the study.

Exclusion criteria:

For HARMONY-Kids:

* Presence of active suicidal ideation and/or need for urgent psychiatric care,
* Patient experiencing a cancer relapse,
* Refusal to participate,
* Pregnant women, women in labor, or breastfeeding mothers,
* Individuals deprived of their liberty, hospitalized without consent, or hospitalized for purposes other than research,
* Individuals subject to legal guardianship or conservatorship, or those unable to give informed consent

For HARMONY-AYA:

* Presence of active suicidal ideation and/or need for urgent psychiatric care,
* Patients experiencing a cancer relapse,
* Refusal to participate,
* Pregnant women, women in labor, or breastfeeding mothers,
* Individuals deprived of their liberty, hospitalized without consent, or hospitalized for purposes other than research,
* Adults subject to legal guardianship or conservatorship, or unable to give informed consent.

Where it's running

  • CENTRE HOSPITALIER UNIVERSITAIRE - site NORD
    Saint-Etienne, France
    Recruiting
  • Centre Hospitalier Universitaire Caen Normandie
    Caen, France
    Not yet recruiting
  • Centre Hospitalier Universitaire Grenoble Alpes
    Grenoble, France
    Not yet recruiting
  • Institut d'Hématologie et d'Oncologie Pédiatrique
    Lyon, France
    Not yet recruiting
  • Centre Hospitalier Universitaire
    Rouen, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.